Zaltrap (aflibercept)

How Much Does that Drug Cost? You Have to be Kidding!

How much money is a drug worth and how much money should we be willing to spend for it have been questions that have been increasingly asked by economists, doctors and cancer survivors. Last month in an Op-Ed article three doctors from Memorial Sloane Kettering Cancer Center in New York (Sloane) let the world know [...]

By Malecare|2012-11-09T10:07:27-05:00November 9th, 2012|Advanced Prostate Cancer, Advocacy, Drugs & Treatments, General Information, How We Live, Medicare/Medicaid, Uncategorized, Zaltrap (aflibercept)|2 Comments

On the Horizon- Final Results of VENICE First-Line Hormone-Refractory Metastatic Prostate Cancer Trial Expected in 2012

Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VENICE clinical trial evaluating the investigational agent Zaltrap (aflibercept) in the first-line treatment of men with castrate resistant prostate cancer will continue to completion as planned. They have not been asked to make any modifications due to efficacy or to safety concerns. This decision is based on [...]

By Malecare|2017-10-19T10:52:18-04:00July 12th, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Uncategorized, Zaltrap (aflibercept)|0 Comments